Abstract
In order to achieve a high efficacy in cancer therapies which use radiation and/or hyperthermia, it is necessary to study and understand two important signal transduction pathways which can depress cell survival signals and simultaneously enhance cell death signals. Recent progress in molecular biology has provided information about these molecules and the associated mechanisms involved in their signaling and functioning. Targeting therapies have thus been examined to look for those which can affect genes capable of inducing a high efficiency in killing cancer cells after exposures to radiation and/or hyperthermia therapies. Target genes which function in cell survival signal transduction pathways, DNA repair, and protein repair are of primary interest. In contrast, apoptosis- and necrosis-inducing factors have an important role in leading to cell death in response to therapies. In this review, results from recent research efforts in Nara University are discussed.
Keywords: p53, signal transduction, radiation, hyperthermia, cancer therapy
Current Signal Transduction Therapy
Title: Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies
Volume: 5 Issue: 3
Author(s): Takeo Ohnishi and Akihisa Takahashi
Affiliation:
Keywords: p53, signal transduction, radiation, hyperthermia, cancer therapy
Abstract: In order to achieve a high efficacy in cancer therapies which use radiation and/or hyperthermia, it is necessary to study and understand two important signal transduction pathways which can depress cell survival signals and simultaneously enhance cell death signals. Recent progress in molecular biology has provided information about these molecules and the associated mechanisms involved in their signaling and functioning. Targeting therapies have thus been examined to look for those which can affect genes capable of inducing a high efficiency in killing cancer cells after exposures to radiation and/or hyperthermia therapies. Target genes which function in cell survival signal transduction pathways, DNA repair, and protein repair are of primary interest. In contrast, apoptosis- and necrosis-inducing factors have an important role in leading to cell death in response to therapies. In this review, results from recent research efforts in Nara University are discussed.
Export Options
About this article
Cite this article as:
Ohnishi Takeo and Takahashi Akihisa, Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies, Current Signal Transduction Therapy 2010; 5 (3) . https://dx.doi.org/10.2174/157436210791920283
DOI https://dx.doi.org/10.2174/157436210791920283 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of dUTPase and Uracil-DNA Repair in Cancer Chemotherapy
Current Protein & Peptide Science Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
Current Medicinal Chemistry Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Current Molecular Medicine Inflammation and Antiangiogenesis in Cancer
Current Medicinal Chemistry Targeting Glioblastoma Stem Cells: Cell Surface Markers
Current Medicinal Chemistry The Role of Zinc in the Treatment of Taste Disorders
Recent Patents on Food, Nutrition & Agriculture Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Antibody-Based Imaging of HER-2: Moving into the Clinic
Current Molecular Medicine The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Clinical Molecular Imaging with PET Agents Other than 18F-FDG
Current Pharmaceutical Biotechnology Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer
Current Cancer Drug Targets Synthesis of New Curcumin-like Pentadienones by O- and C-glycosylation
Current Organic Chemistry Delta Np63 alpha – Responsive microRNA Modulate the Expression of Metabolic Enzymes
Current Pharmaceutical Biotechnology Clinical and Forensic Signs Related to Cocaine Abuse
Current Drug Abuse Reviews Epidemiology of Candida albicans Infections and Role of Non-Candidaalbicans Yeasts
Current Drug Targets New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Current Targets for Anticancer Drug Discovery
Current Drug Targets Design of Peptide Imaging Agents for Whole-body and Intraoperative Molecular Imaging
Current Medicinal Chemistry Ocular Toxicities in Cancer Therapy: Still Overlooked
Current Cancer Therapy Reviews